US FDA approves Sanofi's bleeding disorder therapy
The U.S. Food and Drug Administration approved French drugmaker Sanofi's hemophilia therapy, introducing a new type of ...
Business Insider20h
Novo Nordisk A/S (B Shares) ADRhedged
Historical Prices for Novo Nordisk A/S (B Shares) ADRhedged Sustainability Rating Investment Policy Indices Commodities Currencies Stocks ...
FDA approves Sanofi treatment for hemophilia A or B
The U.S. Food and Drug Administration approved Qfitlia for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult ...
Morningstar15h
MFS International Equity I
It has a smaller weighting in Taiwan Semiconductor Manufacturing, for instance, than most total international stock market indexes and has been trimming its position in Novo Nordisk as growing ...
Morningstar19h
American Funds New Perspective 529A
The strategy was also overweight healthcare and industrials thanks to pharmaceutical picks such as Novo Nordisk NVO and aerospace companies like Airbus. The strategy's focus on multinational ...